2 active not recruiting, 1 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow sarcolipin: new trials by email Literature Review of sarcolipin trials Research Report on sarcolipin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging Injection of indocyanine green (ICG)dye, Near-Infrared Image-Guided, Sentinel Lymph Node (SLN) mapping - Esophageal Cancer | Not applicable | Active not recruiting | Memorial Sloan Kettering Cancer Center | 90 | 2020-05-20 | 2026-07-07 |
| The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. Sentinel lymph node (SLN) biosy +/- lymphadenectomy - Endometrial Cancer, Cervical Cancer | Recruiting | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 500 | 2020-01-02 | 2022-08-17 | |
| Neoadjuvant PD-1 Blockade in Patients With Stage IIB/C Melanoma Pembrolizumab, Wide Excision and Sentinel Lymph Node (SLN) Biopsy - Melanoma | Phase 2 | Active not recruiting | Abramson Cancer Center at Penn Medicine | 86 | 2019-05-06 | 2026-10-09 |
Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Lymphatic Metastasis (1) · Melanoma (1) · Neoplasm Micrometastasis (1) · Uterine Cervical Neoplasms (1)
Abramson Cancer Center at Penn Medicine (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Memorial Sloan Kettering Cancer Center (1)
United States (2) · Italy (1)
Daniela Molena, MD (1) · Fabio Martinelli, MD (1) · Giorgos Karakousis, MD (1)
PMID 22120175, PMID 28577885, PMID 30286945, PMID 30318103, PMID 30353577, PMID 30833435, PMID 31345606, PMID 31450214, PMID 31818860, PMID 31863354, PMID 31871114